OvaRex anti-idiotype antibody targeting the CA 125 antigen: AXO began an open-label Phase II trial

AltaRex Corp. (TSE:AXO), Waltham, Mass.
Product:

Read the full 67 word article

How to gain access

Continue reading with a
two-week free trial.